PeptideDB

Mitochonic Acid 5 1354707-41-7

Mitochonic Acid 5 1354707-41-7

CAS No.: 1354707-41-7

Mitochonic acid 5 binds to mitochondria and improves renal tubular and cardiomyocyte damage. Mitochonic acid 5 regulates
Sales Email:peptidedb@qq.com

This product is for research use only, not for human use. We do not sell to patients.

Mitochonic acid 5 binds to mitochondria and improves renal tubular and cardiomyocyte damage. Mitochonic acid 5 regulates mitochondrial ATP synthesis.

Physicochemical Properties


Molecular Formula C18H13F2NO3
Molecular Weight 329.297531843185
Exact Mass 329.086
Elemental Analysis C, 65.65; H, 3.98; F, 11.54; N, 4.25; O, 14.58
CAS # 1354707-41-7
PubChem CID 76070959
Appearance Light yellow to yellow solid powder
LogP 3.1
Hydrogen Bond Donor Count 2
Hydrogen Bond Acceptor Count 5
Rotatable Bond Count 5
Heavy Atom Count 24
Complexity 487
Defined Atom Stereocenter Count 0
InChi Key BOKQALWNGNLTOC-UHFFFAOYSA-N
InChi Code

InChI=1S/C18H13F2NO3/c19-10-5-6-12(15(20)7-10)17(22)8-13(18(23)24)14-9-21-16-4-2-1-3-11(14)16/h1-7,9,13,21H,8H2,(H,23,24)
Chemical Name

4-(2,4-difluorophenyl)-2-(1H-indol-3-yl)-4-oxobutanoic acid
Synonyms

MA 5 MA-5 Mitochonic Acid 5
HS Tariff Code 2934.99.9001
Storage

Powder-20°C 3 years

4°C 2 years

In solvent -80°C 6 months

-20°C 1 month

Shipping Condition Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs)

Biological Activity


ln Vitro ATP generation in mitochondria is regulated by mitochondrial acid 5 (MA-5), which is not influenced by the electron transport chain or oxidative phosphorylation. Increased mitochondrial oxidation and ATP depletion are caused by mitochondrial malfunction and are linked to regeneration in a range of mitochondrial disorders [1]. The plant growth hormone regulator-3-receptor, from which (MA-5) is derived, controls energy stimulation and lowers mitochondrial oxidation to safeguard mitochondrial function. The MTT assay was used to assess cell viability in order to see the protective impact of mitochondrial acid 5 on asteroid cells in controlled conditions. Treatment with TNFα resulted in a considerable reduction in cell viability. Treatment with mitochondrial acid 5 reduces this effect, but, in a dependent way [2].
ln Vivo In animal models of cardiac reperfusion injury and cisplatin-induced nephropathy, mitochondrial acid 5 (MA-5) enhances renal function. The study aimed to investigate the protective effects of mitochondrial acid 5 on tissue bioavailability. At a peak time of one hour, mitochondria acid 5 raises the Manhattan concentration in a dose-response manner [1].
References

[1]. Mitochonic Acid 5 Binds Mitochondria and Ameliorates Renal Tubular and Cardiac Myocyte Damage. J Am Soc Nephrol. 2016 Jul;27(7):1925-32.

[2]. Mitochonic acid 5 activates the MAPK-ERK-yap signaling pathways to protect mouse microglial BV-2 cells against TNFα-induced apoptosis via increased Bnip3-related mitophagy. Cell Mol Biol Lett. 2018 Apr 5;23:14.


Solubility Data


Solubility (In Vitro) DMSO : ≥ 106.66 mg/mL (~323.90 mM)
H2O : < 0.1 mg/mL
Solubility (In Vivo) Solubility in Formulation 1: ≥ 2.5 mg/mL (7.59 mM) (saturation unknown) in 10% DMSO + 40% PEG300 + 5% Tween80 + 45% Saline (add these co-solvents sequentially from left to right, and one by one), clear solution.
For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 25.0 mg/mL clear DMSO stock solution to 400 μL PEG300 and mix evenly; then add 50 μL Tween-80 to the above solution and mix evenly; then add 450 μL normal saline to adjust the volume to 1 mL.
Preparation of saline: Dissolve 0.9 g of sodium chloride in 100 mL ddH₂ O to obtain a clear solution.

Solubility in Formulation 2: ≥ 2.5 mg/mL (7.59 mM) (saturation unknown) in 10% DMSO + 90% (20% SBE-β-CD in Saline) (add these co-solvents sequentially from left to right, and one by one), clear solution.
For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 25.0 mg/mL clear DMSO stock solution to 900 μL of 20% SBE-β-CD physiological saline solution and mix evenly.
Preparation of 20% SBE-β-CD in Saline (4°C,1 week): Dissolve 2 g SBE-β-CD in 10 mL saline to obtain a clear solution.

Solubility in Formulation 3: ≥ 2.5 mg/mL (7.59 mM) (saturation unknown) in 10% DMSO + 90% Corn Oil (add these co-solvents sequentially from left to right, and one by one), clear solution.
For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 25.0 mg/mL clear DMSO stock solution to 900 μL of corn oil and mix evenly.

 (Please use freshly prepared in vivo formulations for optimal results.)
Preparing Stock Solutions 1 mg 5 mg 10 mg
1 mM 3.0367 mL 15.1837 mL 30.3674 mL
5 mM 0.6073 mL 3.0367 mL 6.0735 mL
10 mM 0.3037 mL 1.5184 mL 3.0367 mL
*Note: Please select an appropriate solvent for the preparation of stock solution based on your experiment needs. For most products, DMSO can be used for preparing stock solutions (e.g. 5 mM, 10 mM, or 20 mM concentration); some products with high aqueous solubility may be dissolved in water directly. Solubility information is available at the above Solubility Data section. Once the stock solution is prepared, aliquot it to routine usage volumes and store at -20°C or -80°C. Avoid repeated freeze and thaw cycles.